MedTrace Logo

Adapt2Quit - An Adaptive Motivational System for Socio-Economically Disadvantaged Smokers

NCT04720625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 757

Last updated 2025-05-01

No results posted yet for this study

Summary

The goal of this research is to test the Adapt2Quit computer program that uses participant input (message rating on how much the text motivational message might influence one to quit smoking) to select and text motivational messages that are more likely to help a user stop smoking. This Adapt2Quit system will be compared with a quitline facilitation-only control (text messages will be sent to facilitate quitline use). The primary research hypothesis is that the Adapt2Quit recommender-selected messages will be more effective than a texting quitline facilitation-only control for smoking cessation among socioeconomically disadvantaged (SED) smokers.

Conditions

  • Tobacco Smoking

Interventions

BEHAVIORAL

Adapt2Quit

Motivational text messages and quitline facilitation text messages will be sent to participants; these participants will receive Adapt2Quit (experimental) messages as well as quitline facilitation messages.

BEHAVIORAL

Control

Quitline facilitation text messages will be sent to participants; these participants will receive quitline facilitation-only messages.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Cancer Institute (NCI)

    collaborator NIH

  • Johns Hopkins University

    collaborator OTHER

  • Baystate Health

    collaborator OTHER

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Rajani Sadasivam, PhD · Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-28
Primary Completion
2024-10-10
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720625 on ClinicalTrials.gov